NANCY PERRONI: Open Payments
NPI 1306025705 · HANOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 13 payments from 9 companies in 2025. Trend: 2023 $529 · 2024 $1,115 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $226 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 2 | $103 |
| Teva Pharmaceuticals USA, Inc. | 1 | $95 |
| Neurocrine BioSciences, Inc. | 2 | $95 |
| ACADIA Pharmaceuticals Inc | 1 | $91 |
| ABBVIE INC. | 2 | $40 |
| Alkermes, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Sunosi, COBENFY, REXULTI, Auvelity, AUSTEDO XR, INGREZZA, NUPLAZID, VRAYLAR.
Industry payments across MA — which companies pay providers there.
